A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).

Francesca  Valdora; Giovanna Cutrona; Serena  Matis; Fortunato Morabito; Carlotta Massucco; Laura  Emionite; Simona Boccardo; Luca Basso; Anna Grazia  Recchia; Sandra Salvi; Francesca Rosa; Massimo  Gentile; Marco  Ravina; Daniele Pace; Angela  Castronovo; Michele  Cilli; Mauro Truini; Massimo Calabrese; Antonino  Nerih; Carlo Emanuele Neumaier; Franco  Fais; Gabriella Baio

doi:10.1016/j.clim.2016.07.013

A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).

Francesca Valdora, Giovanna Cutrona, Serena Matis, Fortunato Morabito, Carlotta Massucco, Laura Emionite, Simona Boccardo, Luca Basso, Anna Grazia Recchia, Sandra Salvi, Francesca Rosa, Massimo Gentile, Marco Ravina, Daniele Pace, Angela Castronovo, Michele Cilli, Mauro Truini, Massimo Calabrese, Antonino Nerih, Carlo Emanuele NeumaierFranco Fais, Gabriella Baio

Applied Medicine

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

7 Downloads (Pure)

Abstract

Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia among adults. Despite its indolent nature, CLL remains an incurable disease. Herein we aimed to monitor CLL disease engraftment and,progression/regression in a xenograft CLL mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI). Spleen contrast enhancement, quantified as percentage change in signal intensity upon USPIO administration, demonstrated a difference due to a reduced USPIO uptake, in the spleens of mice injected with CLL cells (NSG-CLL, n = 71) compared to controls (NSG-CTR, n = 17). These differences were statistically significant both after 2 and 4 weeks from CLL cells injection. In addition comparison of mice treated with rituximab with untreated controls for changes in spleen iron uptake confirmed that it is possible to monitor treatment efficacy in this mouse model of CLL using USPIO-enhanced MRI. Further applications could include the preclinical in vivo monitoring of new therapies and the clinical evaluation of CLL patients.

Original language	English
Pages (from-to)	52-60
Number of pages	9
Journal	Clinical Immunology
Volume	172
Early online date	16 Jul 2016
DOIs	https://doi.org/10.1016/j.clim.2016.07.013
Publication status	Published - Nov 2016

Bibliographical note

This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) [Grant 5 x mille n.9980, (to M.F., F.M. and A. N.)]; AIRC I.G. [n. 14,326 (to M.F.)], [n.10136 and 16,722 (A.N.)], [n.15426 (to F.F.)]. AIRC and Fondazione CaRiCal co-financed Multi Unit Regional Grant 2014 [n.16695 (to F.M.)]. Italian Ministry of Health 5 × 1000 funds (to F.F). A.G R. was supported by Associazione Italiana contro le Leucemie-Linfomi-Mielomi (AIL) Cosenza - Fondazione Amelia Scorza (FAS). S.M. C.M., F.V., L. E., S. B., were supported by AIRC.

Keywords

Chronic Lymphocytic Leukemia (CLL)
magnetic resonance imaging (MRI)
ultra-small superparamagnetic iron oxide (USPIO)
Xenograft NSG mice model
disease monitoring

Access to Document

10.1016/j.clim.2016.07.013Licence: Unspecified

Accepted Manuscript
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Accepted author manuscript, 61.5 MBLicence: CC BY-NC-ND

Cite this

Valdora, F., Cutrona, G., Matis, S., Morabito, F., Massucco, C., Emionite, L., Boccardo, S., Basso, L., Recchia, A. G., Salvi, S., Rosa, F., Gentile, M., Ravina, M., Pace, D., Castronovo, A., Cilli, M., Truini, M., Calabrese, M., Nerih, A., ... Baio, G. (2016). A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI). Clinical Immunology, 172, 52-60. https://doi.org/10.1016/j.clim.2016.07.013

A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI). / Valdora, Francesca ; Cutrona, Giovanna; Matis, Serena et al.
In: Clinical Immunology, Vol. 172, 11.2016, p. 52-60.

Research output: Contribution to journal › Article › peer-review

Valdora, F, Cutrona, G, Matis, S, Morabito, F, Massucco, C, Emionite, L, Boccardo, S, Basso, L, Recchia, AG, Salvi, S, Rosa, F, Gentile, M, Ravina, M, Pace, D, Castronovo, A, Cilli, M, Truini, M, Calabrese, M, Nerih, A, Neumaier, CE, Fais, F & Baio, G 2016, 'A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).', Clinical Immunology, vol. 172, pp. 52-60. https://doi.org/10.1016/j.clim.2016.07.013

@article{f993f371dc1a4490941a952700c345dc,

title = "A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).",

abstract = "Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia among adults. Despite its indolent nature, CLL remains an incurable disease. Herein we aimed to monitor CLL disease engraftment and,progression/regression in a xenograft CLL mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI). Spleen contrast enhancement, quantified as percentage change in signal intensity upon USPIO administration, demonstrated a difference due to a reduced USPIO uptake, in the spleens of mice injected with CLL cells (NSG-CLL, n = 71) compared to controls (NSG-CTR, n = 17). These differences were statistically significant both after 2 and 4 weeks from CLL cells injection. In addition comparison of mice treated with rituximab with untreated controls for changes in spleen iron uptake confirmed that it is possible to monitor treatment efficacy in this mouse model of CLL using USPIO-enhanced MRI. Further applications could include the preclinical in vivo monitoring of new therapies and the clinical evaluation of CLL patients.",

keywords = "Chronic Lymphocytic Leukemia (CLL), magnetic resonance imaging (MRI), ultra-small superparamagnetic iron oxide (USPIO), Xenograft NSG mice model, disease monitoring",

author = "Francesca Valdora and Giovanna Cutrona and Serena Matis and Fortunato Morabito and Carlotta Massucco and Laura Emionite and Simona Boccardo and Luca Basso and Recchia, {Anna Grazia} and Sandra Salvi and Francesca Rosa and Massimo Gentile and Marco Ravina and Daniele Pace and Angela Castronovo and Michele Cilli and Mauro Truini and Massimo Calabrese and Antonino Nerih and Neumaier, {Carlo Emanuele} and Franco Fais and Gabriella Baio",

note = "This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) [Grant 5 x mille n.9980, (to M.F., F.M. and A. N.)]; AIRC I.G. [n. 14,326 (to M.F.)], [n.10136 and 16,722 (A.N.)], [n.15426 (to F.F.)]. AIRC and Fondazione CaRiCal co-financed Multi Unit Regional Grant 2014 [n.16695 (to F.M.)]. Italian Ministry of Health 5 × 1000 funds (to F.F). A.G R. was supported by Associazione Italiana contro le Leucemie-Linfomi-Mielomi (AIL) Cosenza - Fondazione Amelia Scorza (FAS). S.M. C.M., F.V., L. E., S. B., were supported by AIRC. ",

year = "2016",

month = nov,

doi = "10.1016/j.clim.2016.07.013",

language = "English",

volume = "172",

pages = "52--60",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).

AU - Valdora, Francesca

AU - Cutrona, Giovanna

AU - Matis, Serena

AU - Morabito, Fortunato

AU - Massucco, Carlotta

AU - Emionite, Laura

AU - Boccardo, Simona

AU - Basso, Luca

AU - Recchia, Anna Grazia

AU - Salvi, Sandra

AU - Rosa, Francesca

AU - Gentile, Massimo

AU - Ravina, Marco

AU - Pace, Daniele

AU - Castronovo, Angela

AU - Cilli, Michele

AU - Truini, Mauro

AU - Calabrese, Massimo

AU - Nerih, Antonino

AU - Neumaier, Carlo Emanuele

AU - Fais, Franco

AU - Baio, Gabriella

N1 - This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) [Grant 5 x mille n.9980, (to M.F., F.M. and A. N.)]; AIRC I.G. [n. 14,326 (to M.F.)], [n.10136 and 16,722 (A.N.)], [n.15426 (to F.F.)]. AIRC and Fondazione CaRiCal co-financed Multi Unit Regional Grant 2014 [n.16695 (to F.M.)]. Italian Ministry of Health 5 × 1000 funds (to F.F). A.G R. was supported by Associazione Italiana contro le Leucemie-Linfomi-Mielomi (AIL) Cosenza - Fondazione Amelia Scorza (FAS). S.M. C.M., F.V., L. E., S. B., were supported by AIRC.

PY - 2016/11

Y1 - 2016/11

N2 - Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia among adults. Despite its indolent nature, CLL remains an incurable disease. Herein we aimed to monitor CLL disease engraftment and,progression/regression in a xenograft CLL mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI). Spleen contrast enhancement, quantified as percentage change in signal intensity upon USPIO administration, demonstrated a difference due to a reduced USPIO uptake, in the spleens of mice injected with CLL cells (NSG-CLL, n = 71) compared to controls (NSG-CTR, n = 17). These differences were statistically significant both after 2 and 4 weeks from CLL cells injection. In addition comparison of mice treated with rituximab with untreated controls for changes in spleen iron uptake confirmed that it is possible to monitor treatment efficacy in this mouse model of CLL using USPIO-enhanced MRI. Further applications could include the preclinical in vivo monitoring of new therapies and the clinical evaluation of CLL patients.

AB - Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia among adults. Despite its indolent nature, CLL remains an incurable disease. Herein we aimed to monitor CLL disease engraftment and,progression/regression in a xenograft CLL mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI). Spleen contrast enhancement, quantified as percentage change in signal intensity upon USPIO administration, demonstrated a difference due to a reduced USPIO uptake, in the spleens of mice injected with CLL cells (NSG-CLL, n = 71) compared to controls (NSG-CTR, n = 17). These differences were statistically significant both after 2 and 4 weeks from CLL cells injection. In addition comparison of mice treated with rituximab with untreated controls for changes in spleen iron uptake confirmed that it is possible to monitor treatment efficacy in this mouse model of CLL using USPIO-enhanced MRI. Further applications could include the preclinical in vivo monitoring of new therapies and the clinical evaluation of CLL patients.

KW - Chronic Lymphocytic Leukemia (CLL)

KW - magnetic resonance imaging (MRI)

KW - ultra-small superparamagnetic iron oxide (USPIO)

KW - Xenograft NSG mice model

KW - disease monitoring

U2 - 10.1016/j.clim.2016.07.013

DO - 10.1016/j.clim.2016.07.013

M3 - Article

SN - 1521-6616

VL - 172

SP - 52

EP - 60

JO - Clinical Immunology

JF - Clinical Immunology

ER -

A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI).

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this